+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-a production



CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-a production



Journal of Immunology 161(8): 36-43




(PDF emailed within 1 workday: $29.90)

Accession: 017797751

Download citation: RISBibTeXText



Related references

CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production. Journal of Immunology 161(8): 4236-4243, 1998

Thalidomide analog 3052 reduces NK activity and PHA-induced proliferation in vitro. Immunology 89(SUPPL 1): 34, 1996

Total synthesis of the novel water soluble camptothecin analog GI 147211C, a potent topoisomerase I inhibitor. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 332, 1993

Discovery of a potent tubulin polymerization inhibitor: synthesis and evaluation of water-soluble prodrugs of benzophenone analog. Bioorganic & Medicinal Chemistry Letters 20(21): 6327-6330, 2011

2-Methyl-2-phthalimidino-glutaric acid, a partially-reduced analog of thalidomide, is a potent inhibitor of B16 melanoma metastases. Abstracts of Papers American Chemical Society 216(1-3): MEDI 219, 1998

The immunomodulatory thalidomide analog CC5013 is a potent receptor tyrosine kinase inhibitor that abolishes vascular endothelial growth factor trophic response in malignant myeloid progenitors. Leukemia Research 27(Supplement 1): S108-S109, 2003

Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations. Antimicrobial Agents and ChemoTherapy 46(11): 3613-3616, 2002

The Immunomodulatory Thalidomide Analog, CC5013, Inhibits Trophic Response to VEGF in AML Cells by Abolishing Cytokine-Induced PI3-Kinase/Akt Activation. Blood 100(11): Abstract No 521, November 16, 2002

High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activation. Protein & Cell 1(12): 1118-1127, 2011

The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters 11(5): 701-704, 12 March, 2001

The effect of thalidomide analogue CC-3052 on apoptosis of lymphocytes and neutrophils in HIV. Immunology 92(SUPPL 1): 3, 1997

Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitro. Clinical & Experimental Immunology 121(3): 472-479, September, 2000

DX-8951F, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant. International Journal Of Cancer. 72(4): 680-686, 1997